Publications by authors named "Andrew Plodkowski"

Claim this Profile
A
A Phase II Study of Cabozantinib in Patients With -Altered Lung Cancers.
Guilherme Harada, Fernando C Santini, Clare J Wilhelm, Rebecca W Repetti, Jason C Chang, Andrew J Plodkowski

JTO Clin Res Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Muscle Loss in Patients With NSCLC Taking Fibrates: Findings From a Retrospective Observational Study.
Rahmi Elahjji, Tahj Blow, Rahul Grover, Maurice A Hurd, Richard F Dunne, Andrew J Plodkowski

J Cachexia Sarcopenia Muscle· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer.
Nicolás Gómez-Banoy, Eduardo Ortiz, Caroline S Jiang, Christian Dagher, Carlo Sevilla, Andrew Plodkowski

medRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer.
Nicolás Gómez-Banoy, Eduardo J Ortiz, Caroline S Jiang, Christian Dagher, Carlo Sevilla, Andrew J Plodkowski

J Clin Invest· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer.
Danish Memon, Adam J Schoenfeld, Darwin Ye, George Fromm, Hira Rizvi, Andrew J Plodkowski

Cancer Cell· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
Rohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, Daniel Muldoon, Hira Rizvi, Andrew J Plodkowski

Clin Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer.
Arielle Elkrief, Biagio Riccuiti, Joao V Alessi, Teng Fei, Hannah L Kalvin, Andrew Plodkowski

Oncologist· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling of Skeletal Muscle and Adipose Tissue Depots in Men with Advanced Prostate Cancer Receiving Different Forms of Androgen Deprivation Therapy.
Tahj A Blow, Anirudh Murthy, Rahul Grover, Emily Schwitzer, David M Nanus, Andrew J Plodkowski

Eur Urol Open Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non-Small Cell Lung Cancer.
Noura J Choudhury, Jessica A Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Andrew Plodkowski

Clin Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228.
Paul K Paik, Pang-Dian Fan, Besnik Qeriqi, Azadeh Namakydoust, Bobby Daly, Andrew Plodkowski

J Thorac Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas.
Arielle Elkrief, Alex Makhnin, Khadeja A Moses, Linda S Ahn, Isabel R Preeshagul, Andrew J Plodkowski

Clin Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade.
Joy A Pai, Matthew D Hellmann, Jennifer L Sauter, Marissa Mattar, Hira Rizvi, Andrew J Plodkowski

Cancer Cell· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of COVID-19 pulmonary manifestations with radiotherapy simulation CT imaging.
Abraham J Wu, Andrew Plodkowski, Michelle Ginsberg, Jacob Shin, Quincey LaPlant

Clin Imaging· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of cardiac calcium burden with overall survival after radiotherapy for non-small cell lung cancer.
Justin M Haseltine, Aditya Apte, Andrew Jackson, Ellen Yorke, Anthony F Yu, Andrew Plodkowski

Phys Imaging Radiat Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune check-point inhibitor-related pneumonitis: acute lung injury with rapid progression and organising pneumonia with less severe clinical disease.
Saira Imran, Andrew Golden, Marc Feinstein, Andrew Plodkowski, Francis Bodd

Histopathology· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioinformatically Expanded Next-Generation Sequencing Analysis Optimizes Identification of Therapeutically Relevant MET Copy Number Alterations in >50,000 Tumors.
James P Solomon, Soo-Ryum Yang, Noura J Choudhury, Ryan N Ptashkin, Nasrin Eslamdoost, Andrew Plodkowski

Clin Cancer Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer.
Adam J Schoenfeld, Hira A Rizvi, Danish Memon, Narek Shaverdian, Matthew J Bott, Andrew J Plodkowski

Clin Cancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels.
Biagio Ricciuti, Xinan Wang, Joao V Alessi, Hira Rizvi, Navin R Mahadevan, Andrew J Plodkowski

JAMA Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in patients with cancer: can baseline radiologic severity and early evolution predict clinical outcomes?
Rocio Perez-Johnston, Jose Araujo-Filho, Anna S Mckenney, Natalie Gangai, Andrew J Plodkowski

Eur Radiol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune biomarkers and response to checkpoint inhibition of BRAF and BRAF non-V600 altered lung cancers.
Yonina R Murciano-Goroff, Terry Pak, Sebastian Mondaca, Jessica R Flynn, Joseph Montecalvo, Andrew J Plodkowski

Br J Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status.
Biagio Ricciuti, Kathryn C Arbour, Jessica J Lin, Amir Vajdi, Natalie Vokes, Andrew J Plodkowski

J Thorac Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra- and inter-reader agreement of iRECIST and RECIST 1.1 criteria for the assessment of tumor response in patients receiving checkpoint inhibitor immunotherapy for lung cancer.
Sandra Huicochea Castellanos, Andrew Pagano, Andrew J Plodkowski, Jeffrey Girshman, Matthew D Hellmann

Lung Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non-Small Cell Lung Cancer.
Jia Luo, Victoria L Martucci, Zoe Quandt, Stefan Groha, Megan H Murray, Andrew J Plodkowski

Clin Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic -Rearranged Lung Cancers.
Noura J Choudhury, Jaime L Schneider, Tejas Patil, Viola W Zhu, Debra A Goldman, Andrew J Plodkowski

JTO Clin Res Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of neoadjuvant chemotherapy and interval debulking surgery on body composition in patients with ovarian cancer.
John Vitarello, Marcus D Goncalves, Qin C Zhou, Alexia Iasonos, Darragh F Halpenny, Andrew Plodkowski

JCSM Clin Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis